Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

371.28
Delayed Data
As of Jan 18
 -2.79 / -0.75%
Today’s Change
340.09
Today|||52-Week Range
543.55
-1.24%
Year-to-Date
Ophthotech Begins Phase II Zimura Study in Stargardt Disease
Jan 17 / Zacks.com - Paid Partner Content
Regeneron, Sanofi Expand Investment in Cemiplimab & Dupilumab
Jan 09 / Zacks.com - Paid Partner Content
Can Biotech Keep Last Year's Momentum Alive in 2018?
Jan 11 / Zacks.com - Paid Partner Content
Stock Market News For Jan 9, 2018
Jan 09 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Celgene to Acquire Impact, J.P. Morgan Healthcare Conference i...
Jan 10 / Zacks.com - Paid Partner Content
FDA Approvals Surge in 2017: Here's a Look at the Numbers
Jan 09 / Zacks.com - Paid Partner Content
AbbVie's Upadacitinib Gains Breakthrough Therapy Designation
Jan 09 / Zacks.com - Paid Partner Content
Momenta Reports Positive Top-Line Data on Antibody M281
Jan 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close374.07
Today’s open374.21
Day’s range369.03 - 374.71
Volume596,372
Average volume (3 months)831,459
Market cap$40.2B
Data as of 4:15pm ET, 01/18/2018

Growth & Valuation

Earnings growth (last year)+39.49%
Earnings growth (this year)+38.23%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+18.44%
P/E ratio33.7
Price/Sales8.79
Price/Book8.91

Competitors

 Today’s
change
Today’s
% change
SHPGShire-0.20-0.14%
VRTXVertex Pharmaceutica...+0.20+0.13%
BAXBaxter International...+1.00+1.47%
ALXNAlexion Pharmaceutic...-1.77-1.45%
Data as of 4:01pm ET, 01/18/2018

Financials

Next reporting dateFebruary 13, 2018
EPS forecast (this quarter)$4.49
Annual revenue (last year)$4.9B
Annual profit (last year)$895.5M
Net profit margin18.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts